Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18928649 | OPIOID FORMULATIONS | October 2024 | March 2025 | Allow | 4 | 1 | 0 | No | No |
| 18441413 | MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE | February 2024 | February 2025 | Allow | 12 | 0 | 1 | No | No |
| 18500595 | OPIOID FORMULATIONS | November 2023 | July 2024 | Allow | 9 | 1 | 2 | No | No |
| 18500603 | OPIOID FORMULATIONS | November 2023 | June 2025 | Abandon | 19 | 2 | 0 | Yes | Yes |
| 18476562 | BILAYER BIONIC DRUG-LOADED HYDROGEL, AND PREPARATION AND APPLICATION THEREOF | September 2023 | October 2024 | Abandon | 12 | 2 | 0 | No | No |
| 18256730 | PROCESS FOR COATING KERATIN MATERIALS | June 2023 | March 2026 | Abandon | 33 | 0 | 1 | No | No |
| 18256159 | REDUCTION OF STICKINESS OF COSMETIC COMPOSITIONS COMPRISING OCTOCRYLENE | June 2023 | February 2026 | Abandon | 32 | 0 | 1 | No | No |
| 18201463 | N-HALAMINE CONTAINING FIBROUS COMPOSITIONS AND USES THEREOF | May 2023 | July 2025 | Abandon | 26 | 1 | 1 | No | No |
| 18033248 | SOLID MATERIAL AND DISPERSION COMPOSITION CONTAINING SAME | April 2023 | December 2025 | Abandon | 32 | 0 | 1 | No | No |
| 18130706 | Antimicrobial Articles | April 2023 | April 2025 | Abandon | 25 | 2 | 1 | No | No |
| 18189010 | COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | March 2023 | May 2025 | Allow | 26 | 2 | 1 | No | No |
| 18024283 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING MICRONIZED METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL | March 2023 | January 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18112869 | WOUND HYDROGEL FOR MANAGING ACUTE AND CHRONIC WOUNDS IN HUMAN AND ANIMALS | February 2023 | March 2026 | Abandon | 36 | 1 | 1 | No | No |
| 18109718 | ENTERIC AEROBIZATION THERAPY | February 2023 | August 2024 | Allow | 18 | 3 | 0 | No | No |
| 18108529 | COMPOSITIONS AND METHODS FOR STYLING HAIR | February 2023 | December 2025 | Abandon | 35 | 0 | 1 | No | No |
| 18161215 | TOPICAL DETOMIDINE FORMULATIONS | January 2023 | September 2025 | Abandon | 31 | 3 | 0 | No | No |
| 18146306 | O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES | December 2022 | September 2025 | Abandon | 33 | 2 | 1 | No | No |
| 18059108 | NOVEL COMPOSITION BASED ON POLYCAFFEOYLQUINIC ACIDS, COSMETIC USE THEREOF AND COSMETIC COMPOSITIONS COMPRISING SAME | November 2022 | October 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17983784 | COSMETIC POWDER COMPOSITE AND COSMETIC COMPOSITION CONTAINING SAME | November 2022 | April 2025 | Abandon | 29 | 2 | 1 | Yes | No |
| 17931786 | Method for promoting wound healing. | September 2022 | January 2026 | Abandon | 40 | 4 | 1 | No | No |
| 17942086 | Personal Care Compositions | September 2022 | November 2025 | Abandon | 38 | 4 | 1 | No | No |
| 17902805 | PERSONAL CARE COMPOSITIONS | September 2022 | October 2024 | Allow | 26 | 2 | 0 | No | No |
| 17815972 | STEM CELL STIMULATING COMPOSITIONS AND METHODS | July 2022 | January 2025 | Abandon | 30 | 4 | 1 | No | No |
| 17758318 | SMART WOUND DRESSINGS | July 2022 | September 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17855765 | COMPOSITIONS AND METHODS FOR STYLING HAIR | June 2022 | January 2026 | Allow | 43 | 3 | 1 | Yes | No |
| 17788573 | OIL-IN-WATER EMULSION SUNSCREEN COSMETIC | June 2022 | January 2026 | Allow | 43 | 2 | 0 | No | No |
| 17838754 | Complexation of Oxybenzone with C-methylresorcin[4]arene | June 2022 | December 2025 | Abandon | 42 | 3 | 1 | No | No |
| 17836079 | Method and System for Preventing Sore Throat in Humans | June 2022 | September 2025 | Allow | 40 | 3 | 0 | No | No |
| 17782466 | Encapsulated fragrance compounds based on natural amino acids | June 2022 | July 2025 | Allow | 37 | 0 | 1 | No | No |
| 17752325 | FILM WITH LATERALLY ADJOINED STRIPS FOR ADMINISTRATION OF A VACCINE | May 2022 | March 2026 | Abandon | 45 | 2 | 1 | No | No |
| 17749470 | SUNSCREEN COMPOSITIONS CONTAINING A COMBINATION OF A LINEAR ULTRAVIOLET RADIATION-ABSORBING POLYETHER AND OTHER ULTRAVIOLET-SCREENING COMPOUNDS | May 2022 | November 2024 | Allow | 30 | 4 | 0 | No | No |
| 17738771 | Method and System for Increasing Beneficial Bacteria and Decreasing Pathogenic Bacteria in the Oral Cavity | May 2022 | December 2024 | Allow | 31 | 1 | 1 | No | No |
| 17773087 | STABILIZATION OF DIMPROPYRIDAZ SUSPENSIONS BY TRIETHYLAMMONIUM CHLORIDE | April 2022 | December 2024 | Allow | 32 | 0 | 0 | No | No |
| 17731534 | LIPID DEPOT FORMULATIONS | April 2022 | February 2025 | Abandon | 33 | 2 | 1 | No | No |
| 17771996 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | April 2022 | October 2025 | Allow | 42 | 1 | 1 | Yes | No |
| 17769987 | COMPOSITIONS AND METHODS FOR DELIVERING EXOSOMES USING MICRONEEDLE DEVICES TO THE SKIN | April 2022 | August 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17768876 | CHEMICAL MODIFICATION OF SILK FIBROIN FOR FABRICATION OF ENZYMATICALLY CROSSLINKED HYDROGELS WITH TUNABLE GELATION KINETICS AND BIOACTIVITY | April 2022 | April 2025 | Allow | 36 | 1 | 0 | Yes | No |
| 17753814 | DRIFT CONTROL ADJUVANT FORMULATION CONTAINING A SULFOPOLYMER | March 2022 | April 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17689506 | High-Efficiency Transdermal Patches | March 2022 | January 2025 | Abandon | 35 | 3 | 0 | No | No |
| 17637986 | COPPER-ATSM FOR TREATING NEURODEGENERATIVE DISORDERS ASSOCITED WITH MITOCHONDRIAL DYSFUNCTION | February 2022 | August 2025 | Abandon | 42 | 1 | 1 | No | No |
| 17612512 | COMPOSITION COMPRISING SORBITOL OR XYLITOL, AND A GELLING AGENT | November 2021 | April 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17607920 | EMBOSSED DISPERSIBLE WET WIPES | November 2021 | August 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17501463 | JAB1 Inhibitory Compositions for Ossification and Methods Related Thereto | October 2021 | April 2025 | Allow | 42 | 4 | 0 | No | No |
| 17500198 | ANHYDROUS ALCOHOL-FREE SILKY FRAGRANCE FORMULATION | October 2021 | July 2025 | Abandon | 45 | 5 | 0 | Yes | No |
| 17601521 | Vaginal Tablet Formulation | October 2021 | October 2025 | Allow | 49 | 3 | 1 | No | No |
| 17601530 | OIL-IN-WATER CLEANSING COSMETIC COMPOSITION | October 2021 | January 2026 | Allow | 51 | 3 | 0 | Yes | No |
| 17490652 | MINERAL SUNSCREEN COMPOSITIONS WITH HIGH SPF AND SHELF STABILITY | September 2021 | February 2026 | Allow | 53 | 6 | 0 | No | Yes |
| 17600048 | THERAPEUTIC HYDROGEL DEVICE | September 2021 | August 2025 | Allow | 47 | 2 | 0 | No | No |
| 17439854 | PROPYLENE OXIDE CAPPED LIQUID POLYMERIC SURFACTANTS FOR AGRICULTURAL COMPOSITIONS AND AGRICULTURAL COMPOSITIONS INCLUDING PESTICIDE | September 2021 | August 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17435926 | COSMETIC EMULSION FOR SELF-TANNING | September 2021 | September 2025 | Abandon | 49 | 5 | 0 | No | No |
| 17431379 | METHODS AND COMPOSITIONS FOR ALTERING TEETH | August 2021 | December 2025 | Abandon | 52 | 3 | 0 | No | No |
| 17394623 | NICOTINE PARTICLES AND COMPOSITIONS | August 2021 | August 2025 | Abandon | 48 | 3 | 0 | Yes | Yes |
| 17382893 | COMPOSITION COMPRISING A UV-SCREENING AGENT, AN ANIONIC CROSSLINKED HYDROPHILIC POLYMER, A SURFACTANT HAVING AN HLB LESS THAN OR EQUAL TO 5 AND A SILICONE COPOLYMER | July 2021 | November 2024 | Abandon | 40 | 4 | 1 | No | No |
| 17425244 | COSMETIC/DERMATOLOGICAL COMPOSITION | July 2021 | January 2026 | Allow | 53 | 5 | 2 | Yes | No |
| 17423331 | DIESTER OF PLANT-BASED 1,3-PROPANEDIOL | July 2021 | November 2024 | Abandon | 41 | 1 | 1 | No | No |
| 17415663 | OIL-IN-WATER COSMETIC AND METHOD FOR PRODUCING THE SAME | June 2021 | April 2025 | Abandon | 46 | 2 | 1 | No | No |
| 17319325 | DPP IV INHIBITOR FORMULATIONS | May 2021 | June 2024 | Allow | 37 | 2 | 1 | No | No |
| 17244111 | SUNSCREEN SPRAY | April 2021 | September 2025 | Abandon | 53 | 5 | 1 | Yes | No |
| 17242219 | ACTIVE AGENT-ELUTING HEMOSTATIC AGENTS FOR PREVENTION OF SURGICAL SITE INFECTION | April 2021 | April 2025 | Allow | 48 | 4 | 1 | Yes | No |
| 17285801 | COMPOSITION AND METHOD OF INHIBITING MINERALOCORTICOID RECEPTOR ACTIVITY BY APPLYING IT TO THE SKIN | April 2021 | March 2026 | Abandon | 59 | 6 | 0 | Yes | No |
| 17187512 | METHODS AND COMPOSITIONS USING SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT | February 2021 | February 2025 | Abandon | 47 | 1 | 1 | No | No |
| 17267319 | EMULSION COSMETIC | February 2021 | February 2026 | Allow | 60 | 7 | 0 | Yes | No |
| 17267332 | EMULSION COSMETIC | February 2021 | May 2025 | Allow | 52 | 6 | 0 | Yes | No |
| 17266567 | ANTIOXIDANT COMPOSITION COMPRISING NOVEL GINSENOSIDE | February 2021 | October 2024 | Abandon | 44 | 2 | 0 | No | No |
| 17125942 | HYDROGLYCOLIC COSMETIC COMPOSITION WITH A HIGH ACTIVE CONTENT | December 2020 | July 2025 | Allow | 54 | 7 | 1 | Yes | Yes |
| 16973904 | PERSONAL CARE FORMULATIONS COMPRISING THICKENED ORGANIC LIQUIDS | December 2020 | November 2024 | Abandon | 48 | 5 | 1 | No | No |
| 17041064 | METHOD FOR THE PREPARATION OF A BASE FORMULATION FOR A DERMATOLOGICAL SUNSCREEN COMPOSITION AND FOR THE PREPARATION OF A DERMATOLOGICAL SUNSCREEN COMPOSITION | September 2020 | July 2025 | Allow | 57 | 6 | 1 | No | No |
| 16982338 | RAW MATERIAL FOR COSMETIC AND OIL-IN-WATER EMULSION COSMETIC COMPRISING CORE-CORONA POLYMER PARTICLE | September 2020 | November 2024 | Abandon | 50 | 4 | 0 | Yes | Yes |
| 16975418 | POROUS BIOMATERIALS FOR TISSUE REGENERATION | August 2020 | November 2024 | Allow | 51 | 5 | 0 | No | No |
| 16909635 | TABLETS CONTAINING ARGININE AT HIGH CONCENTRATION | June 2020 | May 2025 | Abandon | 59 | 7 | 0 | Yes | No |
| 16954402 | ANTIMICROBIAL LAYERED MATERIAL | June 2020 | September 2024 | Allow | 51 | 4 | 1 | Yes | No |
| 16768449 | OZONE NANOBUBBLE ANTICANCER AGENT | May 2020 | January 2026 | Abandon | 60 | 7 | 0 | Yes | No |
| 16878993 | COMPOSITIONS AND METHODS FOR TREATING HAIR | May 2020 | November 2025 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 16819408 | ADHESIVE SHEET FOR APPLICATION TO THE SKIN, AND PERCUTANEOUS ABSORPTION PREPARATION USING SAME | March 2020 | July 2025 | Abandon | 60 | 3 | 0 | No | Yes |
| 16635372 | Treatment of Mosaic Viruses and Bacterial Infections of Plants | January 2020 | October 2024 | Abandon | 57 | 5 | 0 | No | No |
| 16388131 | SKIN MARKING SOLUTION AND METHOD OF USE | April 2019 | January 2026 | Allow | 60 | 7 | 0 | Yes | No |
| 16312832 | MICROCAPSULES ENCAPSULATING LAMBDA-CYHALOTHRIN | December 2018 | November 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16306096 | IMPROVED HAIR CARE COMPOSITIONS | November 2018 | March 2020 | Allow | 15 | 1 | 0 | No | No |
| 16189102 | ODOR CONTROL COMPOSITION AND METHOD OF USING | November 2018 | December 2025 | Allow | 60 | 8 | 1 | Yes | Yes |
| 16097980 | PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS | October 2018 | February 2026 | Abandon | 60 | 3 | 1 | Yes | No |
| 16035762 | ENHANCED EFFICIENCY OF SUNSCREEN COMPOSITIONS | July 2018 | July 2024 | Allow | 60 | 4 | 1 | No | Yes |
| 16065952 | Antifungal Agent | June 2018 | June 2020 | Abandon | 24 | 6 | 1 | Yes | Yes |
| 16062124 | COMPOSITION OF GEL/GEL TYPE BASED ON HYDROPHOBIC COATED PIGMENTS AND A LIQUID FATTY ACID AND/OR A GLYCOL COMPOUND | June 2018 | December 2025 | Allow | 60 | 8 | 1 | Yes | Yes |
| 15638059 | SKIN COMPOSITIONS AND METHODS OF USE THEREOF | June 2017 | December 2025 | Allow | 60 | 16 | 0 | No | No |
| 14818212 | METHOD OF SELECTING ANTIOXIDANTS FOR USE IN TOPICALLY APPLIED COMPOSITIONS | August 2015 | June 2018 | Allow | 35 | 4 | 0 | Yes | Yes |
| 13335151 | METHODS AND COMPOSITIONS FOR TREATING ACNE | December 2011 | August 2012 | Allow | 7 | 2 | 0 | Yes | No |
| 13103393 | HIGH PHOTOSTABILITY SUNSCREEN COMPOSITION | May 2011 | August 2013 | Allow | 27 | 1 | 0 | No | No |
| 12879413 | WATER-INSOLUBLE MEDICINE | September 2010 | November 2012 | Allow | 27 | 2 | 1 | Yes | No |
| 12511800 | SYNTHESIS OF NANOPARTICLES BY FUNGI | July 2009 | January 2013 | Allow | 41 | 2 | 1 | No | No |
| 12169764 | PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION OF POORLY SOLUBLE COMPOUNDS | July 2008 | May 2012 | Allow | 46 | 2 | 1 | No | Yes |
| 12149058 | Melt formula | April 2008 | May 2013 | Allow | 60 | 2 | 0 | No | No |
| 11722284 | INFECTION-RESISTANT POLYURETHANE FOAMS, METHOD FOR PRODUCING THE SAME AND USE THEREOF IN ANTISEPTIC WOUND DRESSINGS | June 2007 | December 2011 | Allow | 54 | 2 | 1 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner YU, HONG.
With a 30.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 23.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner YU, HONG works in Art Unit 1614 and has examined 52 patent applications in our dataset. With an allowance rate of 55.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 51 months.
Examiner YU, HONG's allowance rate of 55.8% places them in the 16% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by YU, HONG receive 4.17 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by YU, HONG is 51 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +4.8% benefit to allowance rate for applications examined by YU, HONG. This interview benefit is in the 29% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 13.4% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 17.4% of cases where such amendments are filed. This entry rate is in the 20% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 87.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 66% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 56.5% of appeals filed. This is in the 29% percentile among all examiners. Of these withdrawals, 38.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 46.2% are granted (fully or in part). This grant rate is in the 40% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.